Sperber, Pia S.
Brandt, Alexander U.
Zimmermann, Hanna G.
Bahr, Lina S.
Chien, Claudia
Rekers, Sophia
Mähler, Anja
Böttcher, Chotima
Asseyer, Susanna
Duchow, Ankelien Solveig
Bellmann-Strobl, Judith
Ruprecht, Klemens
Paul, Friedemann
Schmitz-Hübsch, Tanja
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 2 June 2022
Accepted: 10 November 2022
First Online: 14 December 2022
Declarations
:
: The study was approved by the institutional ethics committee of Charité – Universitätsmedizin Berlin (EA1/362/20) and we follow guidelines framed by the Declaration of Helsinki for the conduction of the study. Before study entry, each participant gives written informed consent.
: Written informed consent for publication of results will be obtained from all study participants by the study physician.
: PSS, AUB, LSB, SR, AM, CB, ASD, FP have nothing to disclose.
: JBS has received speaking honoraria and travel grants from Bayer Healthcare, sanofi-aventis/Genzyme, and Biogen, in addition received compensation for serving on a Scientific Advisory board of Roche, not related to the presented work.
: HGZ received research grants from Novartis and speaking honoraria from Bayer.
: KR received research support from Novartis Pharma, Merck Serono, German Ministry of Education and Research, European Union (821283-2), Stiftung Charité and Arthur Arnstein Foundation, and travel grants from Guthy Jackson Charitable Foundation.
: TSH received speaker’s honoraria from Bayer and Biogen research funding to institution from Roche pharma and Celgene/bms.
: SA received a conference grant from Celgene and honoraria for lecturing from Alexion, Bayer, and Roche.
: CC received honoraria for lecturing from Bayer and research funding from Novartis.